BioPATH: A Biomarker Study in Asian Patients With HER2+ Advanced Breast Cancer Treated With Lapatinib and Other Anti-Her2 Therapy
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2018.598
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2019
Authors
Publisher
Korean Cancer Association